Standard of Care Surgery

PROCEDURE6 trials

Conditions

Bladder CancerBladder TumorCarcinoma, Non-Small-Cell-LungChronic Subdural HematomaFacial ParalysisHead and Neck CancerNon-Small Cell Lung CancerNonsmall Cell Lung Cancer

Early Phase 1

Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)

WithdrawnNCT02419170

Washington University School of MedicineCarcinoma, Non-Small-Cell-Lung, Nonsmall Cell Lung Cancer, Non-Small Cell Lung Cancer

Start: 2016-07-31End: 2023-10-31Updated: 2016-07-18

Phase 2

Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity

Active, not recruitingNCT02919683

Dana-Farber Cancer InstituteHead and Neck Cancer

Start: 2016-11-01End: 2026-12-01Updated: 2026-01-28

Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention

WithdrawnNCT03517995

H. Lee Moffitt Cancer Center and Research InstituteBladder Cancer, Bladder Tumor, Urothelial Carcinoma

Start: 2020-04-30End: 2022-12-31Updated: 2020-05-28

Phase 4

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery

RecruitingNCT04205916

Ophthalmic Consultants of Long IslandPatient Preference

Start: 2019-11-04End: 2020-12-01Target: 50Updated: 2019-12-20

Unknown Phase

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

CompletedNCT04816591

Cerenovus, Part of DePuy Synthes Products, Inc.Chronic Subdural Hematoma

Start: 2021-05-27End: 2025-03-26Updated: 2026-08-28

Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome

RecruitingNCT06335719

The Cleveland ClinicFacial Paralysis

Start: 2023-03-01End: 2026-12-31Target: 20Updated: 2025-07-30

JAMA Neurology2026-06-15

Middle Meningeal Artery Embolization with n‐Butyl Cyanoacrylate for the Treatment of Subdural Hematomas: The MEMBRANE Study Design

Stroke Vascular and Interventional Neurology2025-09-17

Managing non-acute subdural hematoma using liquid materials: a Chinese randomized trial of middle meningeal artery treatment (MAGIC-MT)-protocol.

2023-09-1413 citations

Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy.

2022-07-07302 citations

Use of Fluoro-[<sup>18</sup>F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers

JAMA Otolaryngology–Head & Neck Surgery2022-01-2013 citations

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma

JAMA Oncology2020-08-27321 citations

New Hope for Immunotherapies in Head & Neck Carcinoma

Oncology Times2017-12-12